ESG

A new partnership moves past simple endorsements, offering Baylor athletes internships and career skills, setting a new standard for corporate NIL deals.

A new AI platform, Alti, claims to boost productivity and retention by creating a 'digital twin' to optimize employee well-being. But can it deliver?

Despite missing its primary goal, Cadrenal Therapeutics' drug CAD-1005 drastically cut deadly blood clots, setting up a crucial FDA meeting for a new path forward.

Alloy producer Afarak's profits plummet despite rising revenue, revealing the harsh realities of currency woes, cheap imports, and a stalled market.

Kenai Therapeutics hires a Novartis M&A veteran as CBO, signaling an aggressive strategy to advance its groundbreaking iPSC cell therapy for Parkinson's disease.

EPIC Insurance creates a new leadership role for Miranda Rodriguez, a strategic move to scale its real estate practice and challenge market leaders.

Fastest-growing US professional skincare brand HYDRINITY partners with VeraSeaCosmetics, bringing its regenerative science to France's $5.4B beauty scene.

A new study links daily mango and avocado to better vascular function, but what does the science—and the funding—really tell us about this fruity fix?

A new OB/GYN-founded brand, Alubri, aims to elevate intimate care with clinical rigor, targeting the underserved perimenopause and menopause market.

With a new CRO and a major retail push, can the values-led organic drink company replicate its foodservice success against CPG giants? We investigate.

A new study of 500+ leaders shows most firms use AI superficially, facing intense ROI pressure, governance hurdles, and a growing talent gap.

As millions of solar panels near retirement, one Tennessee facility is turning a potential waste crisis into a sustainable manufacturing success story.

A new report on 1,800+ patients reveals a model for obesity care that preserves muscle, sustains weight loss, and may solve the GLP-1 cost crisis.

As phosphorus becomes a critical U.S. mineral, one firm's tech helps farmers cut fertilizer use by 50% while boosting profits and food security.

With a massive Series A, Alveus Therapeutics is advancing novel drugs aiming for more durable and higher-quality weight loss than current blockbusters.

Fresh off strong 2025 earnings, AtriCure will detail its growth strategy and innovative cardiac portfolio at a major life sciences conference.

After a pivotal trial failure, Alector will present its new strategy at a key health conference, focusing on its innovative brain-delivery platform.

The maker of Wegovy and Ozempic announces a massive price cut. We explore what this means for patients, competitors, and the future of drug pricing.

With a promise of cellular renewal via exosomes, (plated) Skin Science is leading a biotech revolution. But can it navigate the hype and regulatory hurdles?

Larimar Therapeutics' nomlabofusp receives Breakthrough Therapy Designation, paving an accelerated path for a potential disease-modifying treatment.